(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Fascioliasis D005211 3 associated lipids
Fatigue D005221 10 associated lipids
Fatty Liver D005234 48 associated lipids
Fetal Macrosomia D005320 3 associated lipids
Forearm Injuries D005543 1 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Gastroenteritis D005759 4 associated lipids
Glioma D005910 112 associated lipids
Glycogen Storage Disease Type I D005953 4 associated lipids
Glycogen Storage Disease D006008 4 associated lipids
Glycogen Storage Disease Type III D006010 2 associated lipids
Glycosuria D006029 10 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Heart Septal Defects D006343 2 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Hepatitis, Chronic D006521 3 associated lipids
Hepatitis, Viral, Human D006525 3 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperglycemia D006943 21 associated lipids
Hyperglycemic Hyperosmolar Nonketotic Coma D006944 4 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperlipidemia, Familial Combined D006950 9 associated lipids
Hypertension D006973 115 associated lipids
Hypocalcemia D006996 12 associated lipids
Hypoglycemia D007003 13 associated lipids
Hyponatremia D007010 5 associated lipids
Hypopituitarism D007018 7 associated lipids
Hypothyroidism D007037 32 associated lipids
Infant, Newborn, Diseases D007232 9 associated lipids
Insulin Coma D007331 2 associated lipids
Insulin Resistance D007333 99 associated lipids
Intestinal Diseases D007410 6 associated lipids
Jaundice D007565 4 associated lipids
Kearns-Sayre Syndrome D007625 2 associated lipids
Ketosis D007662 13 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Lacrimal Apparatus Diseases D007766 1 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Lipidoses D008064 7 associated lipids
Lipoma D008067 1 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Liver Diseases D008107 31 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mastitis D008413 3 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
De Pergola G et al. D-(-)-beta-hydroxybutyrate inhibits catecholamine-stimulated lipolysis and decreases beta-adrenoceptors' affinity in human fat cells but not in lymphomonocytes. 1990 Acta Endocrinol. pmid:2159203
Gillmer MD et al. Low energy diets in the treatment of gestational diabetes. 1986 Acta Endocrinol Suppl (Copenh) pmid:3532669
Aarsen RS et al. Long-acting somatostatin analogue (Sandostatin) reduces late night insulinopenic ketogenesis in diabetic teenagers. 1987 Acta Endocrinol Suppl (Copenh) pmid:2892337
Avogaro A et al. Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes. 1990 Jan-Mar Acta Diabetol Lat pmid:2336923
Al-Awadi F and Shoukry M The lipid lowering effect of an anti-diabetic plant extract. 1988 Jan-Mar Acta Diabetol Lat pmid:3407374
Stangenberg M et al. Effect of treatment with insulin or diet on intermediary metabolites in pregnant women with chemical diabetes in the third trimester of pregnancy. 1984 Jan-Mar Acta Diabetol Lat pmid:6375226
Micossi P et al. Metabolic instability in type I diabetic patients. Studies on insulin absorption, hepatic production of metabolites and glucose counterregulation. 1985 Jul-Sep Acta Diabetol Lat pmid:3907236
Gregorio F et al. Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations. 1990 Apr-Jun Acta Diabetol Lat pmid:2198745
Hoque MM et al. Structure of D-3-hydroxybutyrate dehydrogenase prepared in the presence of the substrate D-3-hydroxybutyrate and NAD+. 2009 Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. pmid:19342772
Faria MH et al. Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats. 2007 Mar-Apr Acta Cir Bras pmid:17375219